Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 03/25/25 → 07/10/25 |
Funding
- Incyte Corporation: $20,000.00
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis
- Salvemini, Joann (PI)
- Kaufmann, Tara (CoPI)
- Hugh, Jeremy (CoPI)
Project: Research